COMPARATIVE EFFICACY AND SAFETY OF TWO HYALURONANS F60027 (STRUCTOVIAL) AND HYLAN G-F20 (SYNVISC) IN KNEE OSTEOARTHRITIS (KOA)

被引：0
|
作者：
Berenbaum, F. [1 ]
Zaim, M. [2 ]
Appelboom, T. [3 ]
Jeka, S. [4 ]
Trc, T. [5 ]
Maasalu, K. [6 ]
Hucher, M. [7 ]
Maheu, E. [1 ]
机构：
[1] Hop St Antoine, F-75571 Paris, France
[2] Lab Pierre Fabre, Ramonville St Agne, France
[3] Erasmus Hosp, Brussels, Belgium
[4] Nzoz Nasz Lekarz, Torun, Poland
[5] Ortoped Klin UK 2LF Fn Motol, Prague, Czech Republic
[6] Ortopeedia Kliiniliste Uuringute Keskus, Tartu, Estonia
[7] Pierre Fabre Biometry, Labege, France
来源：
OSTEOPOROSIS INTERNATIONAL | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [1] Comparative efficacy and safety of two different molecular weight (MW) hyaluronans F60027 and Hylan G-F20 in symptomatic osteoarthritis of the knee (KOA). Results of a non-inferiority, prospective, randomised, controlled trial
    Maheu, E.
    Zaim, M.
    Appelboom, T.
    Jeka, S.
    Tre, T.
    Maasalu, K.
    Berenbaum, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (03) : 527 - 535
  • [2] Osteoarthritis of the knee: Viscosupplementation with hylan G-F20 in clinical practice.
    Lussier, A
    deMedicis, R
    Cividino, AA
    McFarlane, CA
    Olszynski, WP
    Potashner, WJ
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1192 - 1192
  • [3] Intrarticular Hylan G-F 20 (Synvisc)® in the treatment of patients with osteoarthritis of the knee.
    Sharlati, J
    Hatef, M
    Jokar, M
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 3 - 3
  • [4] Open-label multicenter trial of the safety and efficacy of viscosupplementation with hylan G-F 20 (Synvisc) in primary osteoarthritis of the knee
    Wobig, M
    Beks, P
    Dickhut, A
    Maier, R
    Vetter, G
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 1999, 5 (06) : S24 - S31
  • [5] IMPROVEMENTS IN HIP OSTEOARTHRITIS WITH LAVAGE, TRIAMCINOLONE AND HYLAN G-F20
    De Rezende, Marcia Uchoa
    Campos Gurgel, Henrique Melo
    Ocampos, Guilherme Pereira
    De Campos, Gustavo Constantino
    Frucchi, Renato
    Pailo, Alexandre Felicio
    Pasqualin, Thiago
    Negreiros Vicente, Jose Ricardo
    De Camargo, Olavo Pires
    ACTA ORTOPEDICA BRASILEIRA, 2020, 28 (06): : 280 - 286
  • [6] Hylan G-F20 reduces the probability of progression to total knee replacement in knee osteoarthritis.
    Waddell, DD
    Bricker, D
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S49 - S49
  • [7] Prospective study of the safety and efficacy of hylan G-F 20 (Synvisc®) in patients with symptomatic ankle osteoarthritis.
    Witteveen, A. g. h.
    Giannini, S.
    Guido, G.
    Jerosch, J.
    Lohrer, H.
    van Dijk, C. N.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S676 - S676
  • [8] Hylan G-F 20 (Synvisc) for the treatment of osteoarthritis of the knee - Clinical studies and practical considerations
    Wobig, M
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 1999, 5 (06) : S12 - S17
  • [9] Intra-articular hylan G-F 20 (Synvisc®) in the management of patellofemoral osteoarthritis of the knee (POAK)
    Clarke, S
    Lock, V
    Duddy, J
    Sharif, M
    Newman, JH
    Kirwan, JR
    KNEE, 2005, 12 (01): : 57 - 62
  • [10] Efficacy and safety of viscosupplementation with Hylan G-F 20 for the treatment of knee osteoarthritis - A systematic review
    Espallargues, M
    Pons, JMV
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2003, 19 (01) : 41 - 56
12345